Search by Drug Name or NDC

    NDC 00597-0140-70 Tradjenta 5 mg/1 Details

    Tradjenta 5 mg/1

    Tradjenta is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is LINAGLIPTIN.

    Product Information

    NDC 00597-0140
    Product ID 0597-0140_af239154-d1de-4c5c-9a24-32910117d8fd
    Associated GPIs 27550050000320
    GCN Sequence Number 067353
    GCN Sequence Number Description linagliptin TABLET 5 MG ORAL
    HIC3 C4J
    HIC3 Description ANTIHYPERGLYCEMIC, DPP-4 INHIBITORS
    GCN 29890
    HICL Sequence Number 037576
    HICL Sequence Number Description LINAGLIPTIN
    Brand/Generic Brand
    Proprietary Name Tradjenta
    Proprietary Name Suffix n/a
    Non-Proprietary Name linagliptin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name LINAGLIPTIN
    Labeler Name Boehringer Ingelheim Pharmaceuticals, Inc.
    Pharmaceutical Class Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA201280
    Listing Certified Through 2024-12-31

    Package

    NDC 00597-0140-70 (00597014070)

    NDC Package Code 0597-0140-70
    Billing NDC 00597014070
    Package 7 BLISTER PACK in 1 CARTON (0597-0140-70) / 1 TABLET, FILM COATED in 1 BLISTER PACK
    Marketing Start Date 2011-05-09
    NDC Exclude Flag N
    Pricing Information N/A